Search

STAAR Surgical Co

Chiusa

SettoreSettore sanitario

23.42 -3.26

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

23.42

Massimo

24.27

Metriche Chiave

By Trading Economics

Entrata

5.2M

5.2M

Vendite

36M

94M

EPS

0.29

Margine di Profitto

5.567

Dipendenti

921

EBITDA

19M

10M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+29.52% upside

Dividendi

By Acuity

Utili prossimi

12 ago 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-192M

1.2B

Apertura precedente

26.68

Chiusura precedente

23.42

Notizie sul Sentiment di mercato

By Acuity

53%

47%

250 / 340 Classifica in Healthcare

STAAR Surgical Co Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 lug 2026, 18:11 UTC

News

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

21 lug 2026, 16:56 UTC

Social Media

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

20 lug 2026, 20:01 UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Confronto tra pari

Modifica del prezzo

STAAR Surgical Co Previsione

Obiettivo di Prezzo

By TipRanks

29.52% in crescita

Previsioni per 12 mesi

Media 31.33 USD  29.52%

Alto 40 USD

Basso 25 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per STAAR Surgical Co - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

8 ratings

2

Acquista

6

Mantieni

0

Vendi

Sentiment

By Acuity

250 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat